Maternal Omics to Maximize Immunity — MICHAL Aviva ELOVITZ (MASSACHUSETTS INSTITUTE OF TECHNOLOGY)
Overall: Summary From the moment of fertilization to birth, the maternal immune system evolves, adapts, and supports the growth of a fetal allograft that ultimately perpetuates the human race. Immunol
| Project title | Maternal Omics to Maximize Immunity |
|---|---|
| Project number | 1U19AI167899-01 |
| PI name | MICHAL Aviva ELOVITZ |
| Institution | MASSACHUSETTS INSTITUTE OF TECHNOLOGY |
| Funding mechanism | U19 |
| Agency | NIAID |
| Award amount | $2.35M |
| Fiscal year | 2022 |
| Project start | 2022-04-19T00:00:00 |
| Project end | 2027-03-31T00:00:00 |
| Abstract | Overall: Summary From the moment of fertilization to birth, the maternal immune system evolves, adapts, and supports the growth of a fetal allograft that ultimately perpetuates the human race. Immunol |
| Key terms | <0-4 weeks old><2019 novel corona virus><2019 novel coronavirus><2019-nCoV><Allografting><Atlases><A |
$799/mo
Try GrantRadar →